The global market for Autologous Biologics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Autologous Biologics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Autologous Biologics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Autologous Biologics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Autologous Biologics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Autologous Biologics players cover Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics and Opexa Therapeutics, Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Autologous Biologics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Autologous Biologics market, with both quantitative and qualitative data, to help readers understand how the Autologous Biologics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kg.
Market Segmentation:
The study segments the Autologous Biologics market and forecasts the market size by Type (Adipose Tissue, Plasma and Others), by Application (Hospitals, Ambulatory Centers and Research Centers,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Adipose Tissue
Plasma
Others
Segmentation by application
Hospitals
Ambulatory Centers
Research Centers
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Vericel Corporation
BioTime, Inc.
Pharmicell Co.
BrainStorm Cell Therapeutics
Opexa Therapeutics, Inc
Pharmicell Co., Inc
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics
Chapter Introduction
Chapter 1: Scope of Autologous Biologics, Research Methodology, etc.
Chapter 2: Executive Summary, global Autologous Biologics market size (sales and revenue) and CAGR, Autologous Biologics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Autologous Biologics sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Autologous Biologics sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Autologous Biologics market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation and Regenexx and etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Autologous Biologics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Autologous Biologics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Autologous Biologics by Country/Region, 2017, 2022 & 2028
2.2 Autologous Biologics Segment by Type
2.2.1 Adipose Tissue
2.2.2 Plasma
2.2.3 Others
2.3 Autologous Biologics Sales by Type
2.3.1 Global Autologous Biologics Sales Market Share by Type (2017-2022)
2.3.2 Global Autologous Biologics Revenue and Market Share by Type (2017-2022)
2.3.3 Global Autologous Biologics Sale Price by Type (2017-2022)
2.4 Autologous Biologics Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Centers
2.4.3 Research Centers
2.5 Autologous Biologics Sales by Application
2.5.1 Global Autologous Biologics Sale Market Share by Application (2017-2022)
2.5.2 Global Autologous Biologics Revenue and Market Share by Application (2017-2022)
2.5.3 Global Autologous Biologics Sale Price by Application (2017-2022)
3 Global Autologous Biologics by Company
3.1 Global Autologous Biologics Breakdown Data by Company
3.1.1 Global Autologous Biologics Annual Sales by Company (2020-2022)
3.1.2 Global Autologous Biologics Sales Market Share by Company (2020-2022)
3.2 Global Autologous Biologics Annual Revenue by Company (2020-2022)
3.2.1 Global Autologous Biologics Revenue by Company (2020-2022)
3.2.2 Global Autologous Biologics Revenue Market Share by Company (2020-2022)
3.3 Global Autologous Biologics Sale Price by Company
3.4 Key Manufacturers Autologous Biologics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Autologous Biologics Product Location Distribution
3.4.2 Players Autologous Biologics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Autologous Biologics by Geographic Region
4.1 World Historic Autologous Biologics Market Size by Geographic Region (2017-2022)
4.1.1 Global Autologous Biologics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Autologous Biologics Annual Revenue by Geographic Region
4.2 World Historic Autologous Biologics Market Size by Country/Region (2017-2022)
4.2.1 Global Autologous Biologics Annual Sales by Country/Region (2017-2022)
4.2.2 Global Autologous Biologics Annual Revenue by Country/Region
4.3 Americas Autologous Biologics Sales Growth
4.4 APAC Autologous Biologics Sales Growth
4.5 Europe Autologous Biologics Sales Growth
4.6 Middle East & Africa Autologous Biologics Sales Growth
5 Americas
5.1 Americas Autologous Biologics Sales by Country
5.1.1 Americas Autologous Biologics Sales by Country (2017-2022)
5.1.2 Americas Autologous Biologics Revenue by Country (2017-2022)
5.2 Americas Autologous Biologics Sales by Type
5.3 Americas Autologous Biologics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autologous Biologics Sales by Region
6.1.1 APAC Autologous Biologics Sales by Region (2017-2022)
6.1.2 APAC Autologous Biologics Revenue by Region (2017-2022)
6.2 APAC Autologous Biologics Sales by Type
6.3 APAC Autologous Biologics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Autologous Biologics by Country
7.1.1 Europe Autologous Biologics Sales by Country (2017-2022)
7.1.2 Europe Autologous Biologics Revenue by Country (2017-2022)
7.2 Europe Autologous Biologics Sales by Type
7.3 Europe Autologous Biologics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Autologous Biologics by Country
8.1.1 Middle East & Africa Autologous Biologics Sales by Country (2017-2022)
8.1.2 Middle East & Africa Autologous Biologics Revenue by Country (2017-2022)
8.2 Middle East & Africa Autologous Biologics Sales by Type
8.3 Middle East & Africa Autologous Biologics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Autologous Biologics
10.3 Manufacturing Process Analysis of Autologous Biologics
10.4 Industry Chain Structure of Autologous Biologics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Autologous Biologics Distributors
11.3 Autologous Biologics Customer
12 World Forecast Review for Autologous Biologics by Geographic Region
12.1 Global Autologous Biologics Market Size Forecast by Region
12.1.1 Global Autologous Biologics Forecast by Region (2023-2028)
12.1.2 Global Autologous Biologics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Autologous Biologics Forecast by Type
12.7 Global Autologous Biologics Forecast by Application
13 Key Players Analysis
13.1 Vericel Corporation
13.1.1 Vericel Corporation Company Information
13.1.2 Vericel Corporation Autologous Biologics Product Offered
13.1.3 Vericel Corporation Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Vericel Corporation Main Business Overview
13.1.5 Vericel Corporation Latest Developments
13.2 BioTime, Inc.
13.2.1 BioTime, Inc. Company Information
13.2.2 BioTime, Inc. Autologous Biologics Product Offered
13.2.3 BioTime, Inc. Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 BioTime, Inc. Main Business Overview
13.2.5 BioTime, Inc. Latest Developments
13.3 Pharmicell Co.
13.3.1 Pharmicell Co. Company Information
13.3.2 Pharmicell Co. Autologous Biologics Product Offered
13.3.3 Pharmicell Co. Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pharmicell Co. Main Business Overview
13.3.5 Pharmicell Co. Latest Developments
13.4 BrainStorm Cell Therapeutics
13.4.1 BrainStorm Cell Therapeutics Company Information
13.4.2 BrainStorm Cell Therapeutics Autologous Biologics Product Offered
13.4.3 BrainStorm Cell Therapeutics Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 BrainStorm Cell Therapeutics Main Business Overview
13.4.5 BrainStorm Cell Therapeutics Latest Developments
13.5 Opexa Therapeutics, Inc
13.5.1 Opexa Therapeutics, Inc Company Information
13.5.2 Opexa Therapeutics, Inc Autologous Biologics Product Offered
13.5.3 Opexa Therapeutics, Inc Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Opexa Therapeutics, Inc Main Business Overview
13.5.5 Opexa Therapeutics, Inc Latest Developments
13.6 Pharmicell Co., Inc
13.6.1 Pharmicell Co., Inc Company Information
13.6.2 Pharmicell Co., Inc Autologous Biologics Product Offered
13.6.3 Pharmicell Co., Inc Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pharmicell Co., Inc Main Business Overview
13.6.5 Pharmicell Co., Inc Latest Developments
13.7 Neostem
13.7.1 Neostem Company Information
13.7.2 Neostem Autologous Biologics Product Offered
13.7.3 Neostem Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Neostem Main Business Overview
13.7.5 Neostem Latest Developments
13.8 Dendreon Corporation
13.8.1 Dendreon Corporation Company Information
13.8.2 Dendreon Corporation Autologous Biologics Product Offered
13.8.3 Dendreon Corporation Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Dendreon Corporation Main Business Overview
13.8.5 Dendreon Corporation Latest Developments
13.9 Regenexx
13.9.1 Regenexx Company Information
13.9.2 Regenexx Autologous Biologics Product Offered
13.9.3 Regenexx Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Regenexx Main Business Overview
13.9.5 Regenexx Latest Developments
13.10 Cytori Therapeutics
13.10.1 Cytori Therapeutics Company Information
13.10.2 Cytori Therapeutics Autologous Biologics Product Offered
13.10.3 Cytori Therapeutics Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Cytori Therapeutics Main Business Overview
13.10.5 Cytori Therapeutics Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Autologous Biologics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Autologous Biologics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Adipose Tissue
Table 4. Major Players of Plasma
Table 5. Major Players of Others
Table 6. Global Autologous Biologics Sales by Type (2017-2022) & (Kg)
Table 7. Global Autologous Biologics Sales Market Share by Type (2017-2022)
Table 8. Global Autologous Biologics Revenue by Type (2017-2022) & ($ million)
Table 9. Global Autologous Biologics Revenue Market Share by Type (2017-2022)
Table 10. Global Autologous Biologics Sale Price by Type (2017-2022) & (US$/Kg)
Table 11. Global Autologous Biologics Sales by Application (2017-2022) & (Kg)
Table 12. Global Autologous Biologics Sales Market Share by Application (2017-2022)
Table 13. Global Autologous Biologics Revenue by Application (2017-2022)
Table 14. Global Autologous Biologics Revenue Market Share by Application (2017-2022)
Table 15. Global Autologous Biologics Sale Price by Application (2017-2022) & (US$/Kg)
Table 16. Global Autologous Biologics Sales by Company (2020-2022) & (Kg)
Table 17. Global Autologous Biologics Sales Market Share by Company (2020-2022)
Table 18. Global Autologous Biologics Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Autologous Biologics Revenue Market Share by Company (2020-2022)
Table 20. Global Autologous Biologics Sale Price by Company (2020-2022) & (US$/Kg)
Table 21. Key Manufacturers Autologous Biologics Producing Area Distribution and Sales Area
Table 22. Players Autologous Biologics Products Offered
Table 23. Autologous Biologics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Autologous Biologics Sales by Geographic Region (2017-2022) & (Kg)
Table 27. Global Autologous Biologics Sales Market Share Geographic Region (2017-2022)
Table 28. Global Autologous Biologics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Autologous Biologics Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Autologous Biologics Sales by Country/Region (2017-2022) & (Kg)
Table 31. Global Autologous Biologics Sales Market Share by Country/Region (2017-2022)
Table 32. Global Autologous Biologics Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Autologous Biologics Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Autologous Biologics Sales by Country (2017-2022) & (Kg)
Table 35. Americas Autologous Biologics Sales Market Share by Country (2017-2022)
Table 36. Americas Autologous Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Autologous Biologics Revenue Market Share by Country (2017-2022)
Table 38. Americas Autologous Biologics Sales by Type (2017-2022) & (Kg)
Table 39. Americas Autologous Biologics Sales Market Share by Type (2017-2022)
Table 40. Americas Autologous Biologics Sales by Application (2017-2022) & (Kg)
Table 41. Americas Autologous Biologics Sales Market Share by Application (2017-2022)
Table 42. APAC Autologous Biologics Sales by Region (2017-2022) & (Kg)
Table 43. APAC Autologous Biologics Sales Market Share by Region (2017-2022)
Table 44. APAC Autologous Biologics Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Autologous Biologics Revenue Market Share by Region (2017-2022)
Table 46. APAC Autologous Biologics Sales by Type (2017-2022) & (Kg)
Table 47. APAC Autologous Biologics Sales Market Share by Type (2017-2022)
Table 48. APAC Autologous Biologics Sales by Application (2017-2022) & (Kg)
Table 49. APAC Autologous Biologics Sales Market Share by Application (2017-2022)
Table 50. Europe Autologous Biologics Sales by Country (2017-2022) & (Kg)
Table 51. Europe Autologous Biologics Sales Market Share by Country (2017-2022)
Table 52. Europe Autologous Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Autologous Biologics Revenue Market Share by Country (2017-2022)
Table 54. Europe Autologous Biologics Sales by Type (2017-2022) & (Kg)
Table 55. Europe Autologous Biologics Sales Market Share by Type (2017-2022)
Table 56. Europe Autologous Biologics Sales by Application (2017-2022) & (Kg)
Table 57. Europe Autologous Biologics Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Autologous Biologics Sales by Country (2017-2022) & (Kg)
Table 59. Middle East & Africa Autologous Biologics Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Autologous Biologics Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Autologous Biologics Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Autologous Biologics Sales by Type (2017-2022) & (Kg)
Table 63. Middle East & Africa Autologous Biologics Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Autologous Biologics Sales by Application (2017-2022) & (Kg)
Table 65. Middle East & Africa Autologous Biologics Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Autologous Biologics
Table 67. Key Market Challenges & Risks of Autologous Biologics
Table 68. Key Industry Trends of Autologous Biologics
Table 69. Autologous Biologics Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Autologous Biologics Distributors List
Table 72. Autologous Biologics Customer List
Table 73. Global Autologous Biologics Sales Forecast by Region (2023-2028) & (Kg)
Table 74. Global Autologous Biologics Sales Market Forecast by Region
Table 75. Global Autologous Biologics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Autologous Biologics Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Autologous Biologics Sales Forecast by Country (2023-2028) & (Kg)
Table 78. Americas Autologous Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Autologous Biologics Sales Forecast by Region (2023-2028) & (Kg)
Table 80. APAC Autologous Biologics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Autologous Biologics Sales Forecast by Country (2023-2028) & (Kg)
Table 82. Europe Autologous Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Autologous Biologics Sales Forecast by Country (2023-2028) & (Kg)
Table 84. Middle East & Africa Autologous Biologics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Autologous Biologics Sales Forecast by Type (2023-2028) & (Kg)
Table 86. Global Autologous Biologics Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Autologous Biologics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Autologous Biologics Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Autologous Biologics Sales Forecast by Application (2023-2028) & (Kg)
Table 90. Global Autologous Biologics Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Autologous Biologics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Autologous Biologics Revenue Market Share Forecast by Application (2023-2028)
Table 93. Vericel Corporation Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 94. Vericel Corporation Autologous Biologics Product Offered
Table 95. Vericel Corporation Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 96. Vericel Corporation Main Business
Table 97. Vericel Corporation Latest Developments
Table 98. BioTime, Inc. Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 99. BioTime, Inc. Autologous Biologics Product Offered
Table 100. BioTime, Inc. Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 101. BioTime, Inc. Main Business
Table 102. BioTime, Inc. Latest Developments
Table 103. Pharmicell Co. Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 104. Pharmicell Co. Autologous Biologics Product Offered
Table 105. Pharmicell Co. Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 106. Pharmicell Co. Main Business
Table 107. Pharmicell Co. Latest Developments
Table 108. BrainStorm Cell Therapeutics Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 109. BrainStorm Cell Therapeutics Autologous Biologics Product Offered
Table 110. BrainStorm Cell Therapeutics Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 111. BrainStorm Cell Therapeutics Main Business
Table 112. BrainStorm Cell Therapeutics Latest Developments
Table 113. Opexa Therapeutics, Inc Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 114. Opexa Therapeutics, Inc Autologous Biologics Product Offered
Table 115. Opexa Therapeutics, Inc Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 116. Opexa Therapeutics, Inc Main Business
Table 117. Opexa Therapeutics, Inc Latest Developments
Table 118. Pharmicell Co., Inc Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 119. Pharmicell Co., Inc Autologous Biologics Product Offered
Table 120. Pharmicell Co., Inc Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 121. Pharmicell Co., Inc Main Business
Table 122. Pharmicell Co., Inc Latest Developments
Table 123. Neostem Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 124. Neostem Autologous Biologics Product Offered
Table 125. Neostem Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 126. Neostem Main Business
Table 127. Neostem Latest Developments
Table 128. Dendreon Corporation Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 129. Dendreon Corporation Autologous Biologics Product Offered
Table 130. Dendreon Corporation Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 131. Dendreon Corporation Main Business
Table 132. Dendreon Corporation Latest Developments
Table 133. Regenexx Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 134. Regenexx Autologous Biologics Product Offered
Table 135. Regenexx Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 136. Regenexx Main Business
Table 137. Regenexx Latest Developments
Table 138. Cytori Therapeutics Basic Information, Autologous Biologics Manufacturing Base, Sales Area and Its Competitors
Table 139. Cytori Therapeutics Autologous Biologics Product Offered
Table 140. Cytori Therapeutics Autologous Biologics Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 141. Cytori Therapeutics Main Business
Table 142. Cytori Therapeutics Latest Developments
List of Figures
Figure 1. Picture of Autologous Biologics
Figure 2. Autologous Biologics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Autologous Biologics Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Autologous Biologics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Autologous Biologics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Adipose Tissue
Figure 10. Product Picture of Plasma
Figure 11. Product Picture of Others
Figure 12. Global Autologous Biologics Sales Market Share by Type in 2021
Figure 13. Global Autologous Biologics Revenue Market Share by Type (2017-2022)
Figure 14. Autologous Biologics Consumed in Hospitals
Figure 15. Global Autologous Biologics Market: Hospitals (2017-2022) & (Kg)
Figure 16. Autologous Biologics Consumed in Ambulatory Centers
Figure 17. Global Autologous Biologics Market: Ambulatory Centers (2017-2022) & (Kg)
Figure 18. Autologous Biologics Consumed in Research Centers
Figure 19. Global Autologous Biologics Market: Research Centers (2017-2022) & (Kg)
Figure 20. Global Autologous Biologics Sales Market Share by Application (2017-2022)
Figure 21. Global Autologous Biologics Revenue Market Share by Application in 2021
Figure 22. Autologous Biologics Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Autologous Biologics Revenue Market Share by Company in 2021
Figure 24. Global Autologous Biologics Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Autologous Biologics Revenue Market Share by Geographic Region in 2021
Figure 26. Global Autologous Biologics Sales Market Share by Region (2017-2022)
Figure 27. Global Autologous Biologics Revenue Market Share by Country/Region in 2021
Figure 28. Americas Autologous Biologics Sales 2017-2022 (Kg)
Figure 29. Americas Autologous Biologics Revenue 2017-2022 ($ Millions)
Figure 30. APAC Autologous Biologics Sales 2017-2022 (Kg)
Figure 31. APAC Autologous Biologics Revenue 2017-2022 ($ Millions)
Figure 32. Europe Autologous Biologics Sales 2017-2022 (Kg)
Figure 33. Europe Autologous Biologics Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Autologous Biologics Sales 2017-2022 (Kg)
Figure 35. Middle East & Africa Autologous Biologics Revenue 2017-2022 ($ Millions)
Figure 36. Americas Autologous Biologics Sales Market Share by Country in 2021
Figure 37. Americas Autologous Biologics Revenue Market Share by Country in 2021
Figure 38. United States Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Autologous Biologics Sales Market Share by Region in 2021
Figure 43. APAC Autologous Biologics Revenue Market Share by Regions in 2021
Figure 44. China Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Autologous Biologics Sales Market Share by Country in 2021
Figure 51. Europe Autologous Biologics Revenue Market Share by Country in 2021
Figure 52. Germany Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Autologous Biologics Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Autologous Biologics Revenue Market Share by Country in 2021
Figure 59. Egypt Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Autologous Biologics Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Autologous Biologics in 2021
Figure 65. Manufacturing Process Analysis of Autologous Biologics
Figure 66. Industry Chain Structure of Autologous Biologics
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)